Histopathological Determinants of Survival in Resected Cases of Pancreas Cancer
Author(s) -
Steven T. Brower,
Rose Newman,
D Pertsemlidis,
Isadore Kreel,
Arthur H. Aufses
Publication year - 1993
Publication title -
hpb surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.561
H-Index - 26
eISSN - 1607-8462
pISSN - 0894-8569
DOI - 10.1155/1993/83609
Subject(s) - medicine , lymph node , pancreas , lymph , carcinoma , survival rate , pathology , gastroenterology
We have examined the histopathological factors affecting the degree of local spread, regional lymph node (RLN) metastases, and overall survival (O.S.) in a group of 39 cases of resected carcinoma of the exocrine pancreas. Although the mean O.S. for the group was 14.3 months, resected patients without RLN involvement had a mean survival of 24 months. In contrast the mean O.S. rate was 8 months for patients with RLNs involved. Size, tumor location, and histological grade were compared to RLN involvement and O.S. The mean size of primary tumor did not differ significantly between patients with or without RLN's (r.1 versus 4.6cms). However, 7 or 8 T 1 tumors were <4cm and 35% of tumors <4cm were T 1 lesions. In contrast, only of 17 tumors (6%) >4cm was T 1 . Histological grade was correlated with nodal status and O.S. There was a significant difference between histological grade and the presence of metastatic lymph nodes (G1, 37% positive, G2-4.50% positive). Patients with well differentiated tumors had a mean survival of 21 months compared to a mean survival of 10 months for less differentiated tumors ( p <0.05). This difference was even more significant when stratified for nodal status. The patients with well differentiated tumors and no RLN involvement had a mean survival of 32.5 months compared to 8.6 months for well differentiated tumors with RLN involvement. In summary, we have shown that size, histological grade, and local spread predict for nodal status. However, specific patient subsets (G1, node negative) may exhibit an excellent survival when curative pancreas resection is successful.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom